{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:44Z","timestamp":1740108164017,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Unter dem Begriff Pseudolymphom (PSL) versteht man eine benigne, reaktive Lymphoproliferation der Haut, die klinisch und\/oder histologisch ein malignes Lymphom simulieren kann. Die genaue \u00c4tiopathogenese ist bis heute nicht g\u00e4nzlich gekl\u00e4rt. Man unterscheidet die prim\u00e4ren, idiopathischen PSL ohne erkennbare Ursache von den sekund\u00e4ren PSL mit bekanntem Stimulus. Wir berichten \u00fcber das Auftreten von Pseudolymphomen nach einer Behandlung mit medizinischen Blutegeln (Hirudotherapie). Bisher wurden nach bestem Wissen und Gewissen insgesamt nur 9\u00a0F\u00e4lle von kutanen PSL nach Hirudotherapie in der Literatur beschrieben.<\/jats:p>","DOI":"10.1007\/s00105-021-04812-6","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T16:06:05Z","timestamp":1619021165000},"page":"152-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kutane Pseudolymphome nach Hirudotherapie","Cutaneous pseudolymphoma after hirudotherapy"],"prefix":"10.1007","volume":"73","author":[{"given":"Susanne","family":"Hanner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Stroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Enk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"4812_CR1","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/978-3-662-49544-5_108","volume-title":"Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie","author":"CA Sander","year":"2018","unstructured":"Sander\u00a0CA, Flaig\u00a0MJ (2018) Pseudolymphome. In: Plewig\u00a0G, Ruzicka\u00a0T, Kaufmann\u00a0R, Hertl\u00a0M (Hrsg) Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer, Berlin, Heidelberg, S 1937\u20131943"},{"issue":"1","key":"4812_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cup.13532","volume":"47","author":"C Mitteldorf","year":"2020","unstructured":"Mitteldorf\u00a0C, Kempf\u00a0W (2020) Cutaneous pseudolymphoma\u2014A review on the spectrum and a\u00a0proposal for a\u00a0new classification. J\u00a0Cutan Pathol 47(1):76\u201397","journal-title":"J Cutan Pathol"},{"issue":"2","key":"4812_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1346-8138.2011.01263.x","volume":"39","author":"Y Choi","year":"2012","unstructured":"Choi\u00a0Y, Kim\u00a0S\u2011C (2012) Cutaneous pseudolymphoma induced by Hirudo medicinalis therapy. J\u00a0Dermatol 39(2):195\u2013197","journal-title":"J Dermatol"},{"issue":"2","key":"4812_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5114\/ada.2018.75250","volume":"35","author":"M Tupikowska","year":"2018","unstructured":"Tupikowska\u00a0M, Wo\u017aniak\u00a0Z, Wojciechowska-Zdrojowy\u00a0M, Maj\u00a0J, Jankowska-Konsur\u00a0A (2018) Hirudotherapy\u2014a\u00a0rare cause of pseudolymphoma. Postepy Dermatol Alergol 35(2):225\u2013226","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"4812_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4274\/tpd.galenos.2018.6037","volume":"43","author":"SA Temiz","year":"2019","unstructured":"Temiz\u00a0SA, \u00d6zer \u0130, Ataseven\u00a0A, Dursun\u00a0R, F\u0131nd\u0131k\u00a0S (2019) Cutaneous Pseudolymphoma Due to Hirudotherapy. Turk J Parasitol 43(1):50\u201352","journal-title":"Turk J Parasitol"},{"issue":"8","key":"4812_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/1346-8138.12198","volume":"40","author":"E Khelifa","year":"2013","unstructured":"Khelifa\u00a0E, Kaya\u00a0G, Laffitte\u00a0E (2013) Cutaneous pseudolymphomas after leech therapy. J\u00a0Dermatol 40(8):674\u2013675","journal-title":"J Dermatol"},{"issue":"7","key":"4812_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamadermatol.2013.8066","volume":"150","author":"D Altamura","year":"2014","unstructured":"Altamura\u00a0D, Calonje\u00a0E, li Liau\u00a0J, Rogers\u00a0M, Verdolini\u00a0R (2014) Diffuse cutaneous pseudolymphoma due to therapy with medicinal leeches. JAMA Dermatol 150(7):783\u2013784","journal-title":"JAMA Dermatol"},{"issue":"5 Pt 1","key":"4812_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1067\/mjd.2000.110043","volume":"43","author":"J Smolle","year":"2000","unstructured":"Smolle\u00a0J, Cerroni\u00a0L, Kerl\u00a0H (2000) Multiple pseudolymphomas caused by Hirudo medicinalis therapy. J\u00a0Am Acad Dermatol 43(5 Pt 1):867\u2013869","journal-title":"J Am Acad Dermatol"},{"key":"4812_CR9","doi-asserted-by":"publisher","DOI":"10.1515\/jcim-2016-0056","author":"MS Sadati","year":"2019","unstructured":"Sadati MS, Rezaee M, Ghafarpur S, Aslani FS, Dastgheib L, Jahankhah R (2019) Cutaneous lymphoid hyperplasia induced by Hirudo medicinalis (leeches). J\u00a0Complement Integr Med 16(4). https:\/\/doi.org\/10.1515\/jcim-2016-0056","journal-title":"J\u00a0Complement Integr Med"},{"key":"4812_CR10","first-page":"198","volume":"3","author":"H Aktas","year":"2018","unstructured":"Aktas H, Hamidi A, Ertu\u011frul G, Erol H (2018) A case of cutaneous pseudolymphoma induced by medicinal leech application and review of the literature. Arch Clin Exp Med 3:198\u2013200","journal-title":"Clin Exp Med"},{"key":"4812_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7517","author":"M Sepaskhah","year":"2020","unstructured":"Sepaskhah M, Yazdanpanah N, Aslani FS, Jahromi MA (2020) Cutaneous pseudolymphoma as a\u00a0rare adverse effect of medicinal leech therapy: a case report and review of the literature. Cureus 12(4). https:\/\/doi.org\/10.7759\/cureus.7517","journal-title":"Cureus"},{"issue":"4","key":"4812_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.imr.2017.08.001","volume":"6","author":"AK Sig","year":"2017","unstructured":"Sig\u00a0AK, Guney\u00a0M, Uskudar Guclu\u00a0A, Ozmen\u00a0E (2017) Medicinal leech therapy\u2014an overall perspective. Integr Med Res 6(4):337\u2013343","journal-title":"Integr Med Res"},{"issue":"4","key":"4812_CR13","first-page":"790","volume":"19","author":"A Pietrzak","year":"2012","unstructured":"Pietrzak\u00a0A, Kanitakis\u00a0J, Tomasiewicz\u00a0K, Wawrzycki\u00a0B, Koz\u0142owska-\u0141\u00f3j\u00a0J, Dybiec\u00a0E et al (2012) Cutaneous complications of improper leech application. Ann Agric Environ Med 19(4):790\u2013792","journal-title":"Ann Agric Environ Med"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04812-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04812-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04812-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T08:03:23Z","timestamp":1643357003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04812-6"}},"subtitle":["Fallbericht und Literatur\u00fcbersicht","Case report and review"],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4812"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04812-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"type":"print","value":"0017-8470"},{"type":"electronic","value":"1432-1173"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"23 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Hanner, H.\u00a0Stroh, A.\u00a0Enk und J.\u00a0Hoffmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}